(Q37502039)

English

Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study

scientific article published on 25 July 2011

Statements

Dasatinib combined with docetaxel for castration-resistant prostate cancer: results from a phase 1-2 study (English)
John C Araujo
Paul Mathew
Andrew J Armstrong
Edward L Braud
Edwin Posadas
Mathew Lonberg
Gary E Gallick
Géralyn C Trudel
Prashni Paliwal
Shruti Agrawal
Christopher J Logothetis
25 July 2011
118
63-71

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit